PubRank

Carmen Ponte

Author PubWeight™ 9.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC). BMC Microbiol 2009 1.01
2 Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model. Antimicrob Agents Chemother 2002 0.84
3 In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. J Antimicrob Chemother 2007 0.84
4 Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 2007 0.82
5 Adherence of Streptococcus pneumoniae to polystyrene plates, effect of serum on adhesion, and virulence in the gerbil otitis media model. Microb Pathog 2007 0.81
6 In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum. J Antimicrob Chemother 2008 0.81
7 Comment on: Functional relationship between bacterial cell density and the efficacy of antibiotics. J Antimicrob Chemother 2009 0.80
8 Adherence of Streptococcus pneumoniae to polystyrene plates and epithelial cells and the antiadhesive potential of albumin and xylitol. Pediatr Res 2011 0.79
9 Effect of antibiotic treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae strains with different susceptibilities to amoxicillin. Antimicrob Agents Chemother 2004 0.79
10 Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L. Diagn Microbiol Infect Dis 2009 0.79
11 Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae. J Antimicrob Chemother 2005 0.76
12 Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ. Antimicrob Agents Chemother 2005 0.75
13 Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci. Int J Antimicrob Agents 2010 0.75
14 In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae. Int J Antimicrob Agents 2004 0.75
15 Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis. Int J Antimicrob Agents 2006 0.75
16 Impact of ibuprofen therapy in the outcome of experimental pneumococcal acute otitis media treated with amoxicillin or erythromycin. Pediatr Res 2006 0.75
17 Is it possible to achieve bacterial eradication in otitis media with effusion by empirical antibiotic high doses and concomitant administration of acetaminophen? A microbiological and pharmacological study in the gerbil model. Int J Antimicrob Agents 2003 0.75
18 Rational basis for optimizing antibiotic dosing regimens. Folia Med (Plovdiv) 2004 0.75
19 Urine bactericidal activity after administration of gemifloxacin and trovafloxacin single doses in a phase I study. Int J Antimicrob Agents 2002 0.75
20 Optimal co-amoxiclav ratios for inhibiting Escherichia coli strains with different susceptibilities to the compounds. Int J Antimicrob Agents 2005 0.75